Atopic Dermatitis: Identification and Management of Complicating Factors
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease, associated with impaired skin barrier function and an atopic background. Various complicating factors, such as irritants, aeroallergens, food, microbial organisms, contact allergens, sweat, and scratching can induce the development of AD symptoms. Irritants, including soap/shampoo and clothes, can cause itching and eczematous lesions. In addition, young children with AD tend to become sensitized to eggs, milk, or peanuts, while older children and adults more often become sensitized to environmental allergens, such as house dust mites (HDM), animal dander, or pollen. Serum-specific IgE levels and skin prick test reactions to food tend to show high negative predictive values and low specificity and positive predictive values for diagnosing food allergy. On the other hand, AD adult patients tend to have severe skin symptoms and exhibit high HDM-specific IgE levels. Microbial organisms, e.g., and , might contribute to the pathogenetic mechanisms of AD. While sweat plays a major role in maintaining skin homeostasis, it can become an aggravating factor in patients with AD. Furthermore, scratching often exacerbates eczematous lesions. Several patient-specific complicating factors are seen in most cases. The identification and management of complicating factors are important for controlling AD.
Novel drug delivery systems in topical treatment of atopic dermatitis.
Dabhadkar M, Kulkarni M Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40080153 DOI: 10.1007/s00210-025-04002-4.
Buttar P, Mazhar M, Khan J, Jamil M, Abid M, Tipu M Arch Dermatol Res. 2025; 317(1):500.
PMID: 40009233 DOI: 10.1007/s00403-025-04057-6.
Elfadadny A, Samir H, Mandour A, Ragab R, Elshafey B, Alanazi F Animals (Basel). 2025; 15(3).
PMID: 39943182 PMC: 11815913. DOI: 10.3390/ani15030411.
Beneficial effects of ultrafine bubble shower on a mouse model of atopic dermatitis.
Matsumoto A, Imanishi H, Yamanaka-Takaichi M, Hirae M, Tsuruta D, Nakai K Front Immunol. 2025; 15():1483000.
PMID: 39790997 PMC: 11714852. DOI: 10.3389/fimmu.2024.1483000.
Mamale K, Shukla S, Mahale P, Mhaske A, Kaundal R, Shukla R Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39754682 DOI: 10.1007/s00210-024-03741-0.